NCT05444348 Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT) Status RECRUITING Phase NA
NCT05438394 Clinical Study of Safety and Tolerability of Melphalan Hydrochloride for R/R MM Status UNKNOWN Phase PHASE1
NCT05434689 COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05431608 A Study of MCARH109 and MCARH125 in People With Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05429515 Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury Status NOT_YET_RECRUITING Phase PHASE4
NCT05428163 Immunophenotyping of Plasma Cells and Immune Effector Cells in Peripheral Whole Blood and Bone Marrow Samples From Multiple Myeloma (MM) Patients Status COMPLETED Phase N/A
NCT05422027 Selinexor Plus VRd in High Risk Newly Diagnosed Multiple Myeloma Status RECRUITING Phase PHASE1/PHASE2
NCT05414162 Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy Status RECRUITING Phase N/A
NCT05412329 Study of Dual Targeted CD19/BCMA FASTCART GC012F in Relapsed/ Refractory Multiple Myeloma Status UNKNOWN Phase PHASE1
NCT05405387 Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant Status RECRUITING Phase PHASE2
NCT05396885 Study of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma (iMMagine-1) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05393804 A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05393024 Patient With MMRR Treated With Belantamab Mafotidine on Monotherapy Status COMPLETED Phase N/A
NCT05381077 Evaluation of Whole Body Examination by MRI Integrating the "Zero Time Eco" Sequence (ZTE, Pseudo-CT) for the Detection of Bone Lesions in Multiple Myeloma: Comparison With Pet / CT and Whole Body Scanner Status UNKNOWN Phase NA
NCT05378971 Clinical Research of Pomalidomide Maintenance Therapy for Primary Multiple Myeloma Status RECRUITING Phase NA
NCT05372354 A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma Status RECRUITING Phase PHASE1/PHASE2
NCT05366881 cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease Status RECRUITING Phase N/A
NCT05364177 68Ga-pentixather and 68Ga-pentixafor PET/CT in Multiple Myeloma Status UNKNOWN Phase EARLY_PHASE1